Mark E. Bunnage
VRTXMark E. Bunnage serves as officer: EVP, Chief Scientific Officer at Vertex Pharmaceuticals Incorporated (VRTX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
Mark E. Bunnage's Insider Trading at Vertex Pharmaceuticals Incorporated (VRTX)
Buys
0 · $0.00
Sells
5 · $6.39M
Total Shares Bought
0
Total Shares Sold
13,272
Related Insiders
Duncan McKechnie
officer: EVP, Chief Commercial Officer
VRTXSell · Mar 11, 2026
Joy Liu
officer: EVP and Chief Legal Officer
VRTXSell · Mar 2, 2026
Carmen Bozic
officer: EVP and CMO
VRTXSell · Feb 27, 2026
Reshma Kewalramani
director, officer: CEO & President
VRTXSell · Feb 27, 2026
Kristen Ambrose
officer: SVP & Chief Accounting Officer
VRTXSell · Feb 26, 2026
Jonathan Biller
officer: EVP and Chief Legal Officer
VRTXSell · Feb 25, 2026
Edward Morrow Atkinson III
officer: EVP, Chief Technical Ops. Off.
VRTXSell · Feb 25, 2026
Amit Sachdev
officer: EVP Chief Patient & Ext Af Off
VRTXSell · Feb 25, 2026